Department of Surgery
Department of Biomedical Engineering
Dr. Aijun Wang is a Chancellor's Fellow at the University of California, Davis (UC Davis). Currently, he is an Associate Professor of Surgery and of Biomedical Engineering at UC Davis. He is the Vice Chair for Translational Research, Innovation and Entrepreneurship for the Department of Surgery, Co-Director of the Surgical Bioengineering Laboratory, and Dean's Fellow in Entrepreneurship at the UC Davis School of Medicine. He is also a Principal Investigator at the Institute for Pediatric Regenerative Medicine (IPRM) / Shriners Hospitals Pediatric Research Center, Northern California.
Dr. Wang received his Ph.D. in biology from Tsinghua University, Beijing, China, and underwent postdoctoral training at the UC Berkeley Department of Bioengineering and Berkeley Stem Cell Center, with a postdoctoral fellowship from California Institute for Regenerative Medicine (CIRM). He has been a faculty member of UC Davis since 2012.
Dr. Wang's research focuses on developing tools and technologies that combine molecular, cellular, tissue and biomaterial engineering to promote regeneration and restore function. The Wang Group engineers and develops stem cells, extracellular vesicles/nanomedicine and extracellular matrix/biomaterial scaffolds for the treatment of surgical conditions and diseases. The Wang Lab develops and utilizes experimental and naturally-occurring disease models to evaluate regenerative products for accelerated translational application. The Wang Lab also produces clinical-grade stem cell products, carries out investigational new drug (IND)-enabling studies required by the U.S. Food and Drug Administration (FDA) for clinical applications, and conducts human clinical trials.
Dr. Wang has been serving as PI on several major grants supported by NIH/NICHD, NIH/NINDS, the California Institute for Regenerative Medicine (CIRM), the University of California Center for Accelerated Innovation (UC-CAI), the Tobacco-Related Disease Research Program of California (TRDRP), Shriners Hospital for Children and other foundations. Dr. Wang has published over 110 peer-reviewed papers and has received numerous awards, such as the UC Davis Health Deans’ Team Award for Excellence in Research, UC Davis Health Deans’ Fellowship, UC Davis Chancellor's Fellowship, Deloitte QB3 Award for Innovation, the Tony Phillips Research Award from the Children’s Miracle Network (CMN), the Basil O’Connor Starter Scholar Research Award from the March of Dimes Foundation, the NIH/NHLBI Technology Development Award, and the KidneyX: Redesign Dialysis Phase 2 award from the American Society of Nephrology (ASN) and the Department of Health and Human Services (HHS).